First, YouTube subjected viewers to longer unskippable ads. Now, not even pausing your screen will let users escape. The Google-owned platform confirmed Thursday that it has “widely rolled out ...

By Tiffany Hsu and Stuart A. Thompson On YouTube, an ad for the car company Mazda appeared before a video that repeated the racist falsehood that Haitian migrants in Ohio were “eating ducks on t ...

Vice President Kamala Harris’ campaign on Friday launched a new television ad seeking to tie former President Donald Trump to ...

Ryan Routh has never been an employee of BlackRock nor has he appeared in any BlackRock ads. "The video circulating on social media has been manipulated to falsely link Routh to BlackRock." ...

AD&D insurance usually comes with significant coverage limitations, so always read the fine print. AD&D does not pay if the insured died due to natural causes, such as cancer or heart disease.

Connecting local buyers and sellers 24/7. Place your ad now! Get the word out quickly and effectively with our unmatched local reach online, and in print. Whether you're selling a car, a home ...

Add articles to your saved list and come back to them any time. AFL football operations officials and legal counsel gathered in a meeting room at AFL headquarters wringing their hands. “What do ...

GSK plc (LSE/NYSE: GSK) today announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of AREXVY (Respiratory ...

Findings showed a noninferior immune response for both vaccines when coadministered compared with separate administration. Topline results were announced from a phase 3 study assessing the immune ...

AREXVY is approved for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older, as well as individuals 50 ...

2 SHINGRIX is approved for the prevention of shingles (herpes zoster) in adults aged 50 years and older. AREXVY is approved for the prevention of lower respiratory tract disease (LRTD) caused by ...

GSK plc (LSE/NYSE: GSK) today announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of AREXVY (Respiratory ...